# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-24-002290
Filing Date
2024-07-25
Accepted
2024-07-25 08:09:40
Documents
30
Period of Report
2024-07-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | zk2431711.htm | 6-K | 29209
2 | EXHIBIT 99.1 | exhibit_99-1.htm | EX-99.1 | 34735
3 | EXHIBIT 99.2 | exhibit_99-2.htm | EX-99.2 | 42203
4 | EXHIBIT 99.3 | exhibit_99-3.htm | EX-99.3 | 253927
5 | EXHIBIT 99.4 | exhibit_99-4.htm | EX-99.4 | 146416
6 | EXHIBIT 99.5 | exhibit_99-5.htm | EX-99.5 | 94851
7 | EXHIBIT_99.6 | exhibit_99-6.htm | EX-99.6 | 14039
8 |  | exhibit_99-2slide1.jpg | GRAPHIC | 61252
9 |  | exhibit_99-2slide2.jpg | GRAPHIC | 311164
10 |  | exhibit_99-2slide3.jpg | GRAPHIC | 152833
11 |  | exhibit_99-2slide4.jpg | GRAPHIC | 193168
12 |  | exhibit_99-2slide5.jpg | GRAPHIC | 184091
13 |  | exhibit_99-2slide6.jpg | GRAPHIC | 86980
14 |  | exhibit_99-2slide7.jpg | GRAPHIC | 177876
15 |  | exhibit_99-2slide8.jpg | GRAPHIC | 182523
16 |  | exhibit_99-2slide9.jpg | GRAPHIC | 164014
17 |  | exhibit_99-2slide10.jpg | GRAPHIC | 179441
18 |  | exhibit_99-2slide11.jpg | GRAPHIC | 59282
19 |  | exhibit_99-2slide12.jpg | GRAPHIC | 103875
20 |  | exhibit_99-2slide13.jpg | GRAPHIC | 152049
21 |  | exhibit_99-2slide14.jpg | GRAPHIC | 141664
22 |  | exhibit_99-2slide15.jpg | GRAPHIC | 139312
23 |  | exhibit_99-2slide16.jpg | GRAPHIC | 105179
24 |  | exhibit_99-2slide17.jpg | GRAPHIC | 115075
25 |  | exhibit_99-2slide18.jpg | GRAPHIC | 134571
26 |  | exhibit_99-2slide19.jpg | GRAPHIC | 126955
27 |  | exhibit_99-2slide20.jpg | GRAPHIC | 152966
28 |  | image0.jpg | GRAPHIC | 70904
29 |  | image1.jpg | GRAPHIC | 179393
30 |  | image2.jpg | GRAPHIC | 105297
| Complete submission text file | 0001178913-24-002290.txt |  | 5135920

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38807 | Film No.: 241139894
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)